CAS 566-75-6
:16-Chetoestradiolo
- (17Beta)-3,17-Dihydroxyestra-1,3,5(10)-Trien-16-One
- (17β)-3,17-Dihydroxyestra-1,3,5(10)-trien-16-one
- (1Beta,3Alpha,5Beta,7Alpha)-1,3,7-Trihydroxycholan-24-Oic Acid
- (2R,3R)-3-hydroxy-2-methylbutanoic acid
- (3Alpha,5Beta,12Beta)-3,12-Dihydroxycholan-24-Oic Acid
- (3Beta,5Alpha,17Alpha)-Androstane-3,17-Diol
- (5R)-5-hydroxyhexanoic acid
- 1,3,5(10)-Estratriene-3,17β-diol-16-one
- 16-Oxo-17β-estradiol
- 16-Oxoestradiol
- 16-Oxoestradiol-17β
- 16-keto-17β-Estradiol
- 3,17-Beta-Dihydroxyoestra-1,3,5(10)-Trien-16-One
- 3,17β-Dihydroxyestra-1,3,5(10)-trien-16-one
- 3-Hydroxydodecanedioic Acid
- Estra-1,3,5(10)-trien-16-one, 3,17-dihydroxy-, (17β)-
- Estra-1,3,5(10)-trien-16-one, 3,17β-dihydroxy-
- NSC 51169
- Vedi altri sinonimi
16-Keto-17β-estradiol-2,4,15,15,17-d5
CAS:Purezza:95 atom % DColore e forma:White-Yellow SolidPeso molecolare:291.4016-Keto 17b-Estradiol (>85%)
CAS:Prodotto controllatoApplications A metabolite of Estradiol (E888000).
References Ball, P., et al.: Steroids, 33, 563 (1979), Wong, T., et al.: Clin. Chem., 38, 1830 (1992), Xu, X., et al.: J. Clin. Endocrinol. Metab., 84, 3914 (1999), Todorovic, R., et al.: Carcinogenesis, 22, 905 (2001), Travis, R., et al.: Breast Cancer Res., 5, 239 (2003),Formula:C18H22O3Purezza:>85%Colore e forma:NeatPeso molecolare:286.3716-Keto 17beta-Estradiol-d5 (Major)
CAS:Prodotto controllatoApplications A labelled metabolite of Estradiol (E888000).
References Ball, P., et al.: Steroids, 33, 563 (1979), Wong, T., et al.: Clin. Chem., 38, 1830 (1992), Xu, X., et al.: J. Clin. Endocrinol. Metab., 84, 3914 (1999), Todorovic, R., et al.: Carcinogenesis, 22, 905 (2001), Travis, R., et al.: Breast Cancer Res., 5, 239 (2003),Formula:C18H17D5O3Colore e forma:NeatPeso molecolare:291.4Ref: ST-EA-CP-E3016
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta16-Keto-17β-estradiol
CAS:Prodotto controllato16-Keto 17b-estradiol (16KE) is a potent estrogen that binds to the estrogen receptor and inhibits the binding of other estrogens. 16KE has been shown to be effective in inhibiting the growth of Streptococcus faecalis, which is often found in urine samples or as a result of bacterial vaginosis. 16KE also has an anti-angiogenic effect, which may be due to its ability to inhibit angiogenic factors such as vascular endothelial growth factor and angiopoietin 2. 16KE also has hormonal effects on adrenocortical carcinoma cells, leading to decreased cell proliferation and increased apoptosis. This compound may also have an anti-cancer effect by inducing apoptosis and suppressing tumor growth through the inhibition of cancer cell proliferation and stimulation of cancer cell death.
Formula:C18H22O3Purezza:Min. 95%Colore e forma:PowderPeso molecolare:286.37 g/molRef: 3D-FK24760
Prodotto fuori produzione





